L5 Capital Inc. 13D and 13G filings for BriaCell Therapeutics Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-12-12 06:06 am Purchase | 2024-12-10 | 13D | BRIACELL THERAPEUTICS INC BCTX | L5 Capital Inc. | 26,876 10.700% | 517 (+1.96%) | Filing |
| 2024-12-10 06:06 am Purchase | 2024-12-06 | 13D | BRIACELL THERAPEUTICS INC BCTX | L5 Capital Inc. | 26,359 10.500% | 767 (+3.00%) | Filing |
| 2024-12-05 07:45 am Purchase | 2024-12-03 | 13D | BRIACELL THERAPEUTICS INC BCTX | L5 Capital Inc. | 25,592 10.000% | 7,572 (+42.02%) | Filing |
| 2024-05-24 08:58 am Purchase | 2024-05-14 | 13D | BRIACELL THERAPEUTICS INC BCTX | L5 Capital Inc. | 18,020 14.700% | 7,820 (+76.67%) | Filing |
| 2021-09-07 4:05 pm Unchanged | 2021-09-01 | 13D | BRIACELL THERAPEUTICS INC BCTX | L5 Capital Inc. | 10,200 10.000% | 0 (Unchanged) | Filing |
| 2021-08-04 09:43 am Purchase | 2021-08-03 | 13G | BRIACELL THERAPEUTICS INC BCTX | L5 Capital Inc. | 10,200 10.000% | 5,367 (+111.05%) | Filing |